Opioid Withdrawal Symptoms: A Complete Timeline

Key Takeaways

• Opioid withdrawal symptoms typically begin 6 to 24 hours after the last dose, depending on the substance used.
• The acute withdrawal phase peaks around days 2 to 3 and generally subsides within 7 to 10 days.
• Short-acting opioids like heroin and fentanyl produce faster-onset withdrawal than longer-acting substances like methadone (Dolophine/Methadose).
• Post-acute withdrawal syndrome (PAWS) can persist for weeks or months with symptoms like insomnia, anxiety, and cravings.
• Medical detox with medications such as buprenorphine (Suboxone/Sublocade) or clonidine reduces symptom severity and the risk of complications.
• Opioid withdrawal is rarely life-threatening on its own, but dehydration and co-occurring medical conditions can create emergencies.

Opioid withdrawal occurs when someone who has developed physical dependence on opioids stops using them or significantly reduces their dose. The experience is driven by the body’s attempt to recalibrate after prolonged exposure to substances that suppress pain signaling and stimulate reward pathways. While often described as intensely uncomfortable rather than medically dangerous, the withdrawal process follows a broadly predictable timeline that varies based on the specific opioid used, duration of use, and individual health factors.

This guide breaks down each phase of opioid withdrawal, the symptoms associated with each stage, and what medical professionals recommend for safe management.

What Happens During Opioid Withdrawal

Why Withdrawal Occurs

Opioids bind to mu-opioid receptors throughout the brain, spinal cord, and gastrointestinal tract. With repeated use, the body adapts to the constant presence of these substances by downregulating its own endorphin production and adjusting neurotransmitter activity. When opioids are removed, the system is left in a state of imbalance. The sympathetic nervous system — responsible for the body’s fight-or-flight response — rebounds aggressively, producing the constellation of symptoms recognized as opioid withdrawal.

This rebound effect explains why withdrawal symptoms are essentially the opposite of opioid effects: where opioids cause constipation, withdrawal causes diarrhea; where opioids suppress pain, withdrawal amplifies it; where opioids induce calm, withdrawal produces anxiety and agitation.

Short-Acting vs. Long-Acting Opioids

The timeline of withdrawal depends heavily on the pharmacokinetic profile of the specific opioid involved.

Short-acting opioids (heroin, fentanyl, oxycodone, hydrocodone) have shorter half-lives. Withdrawal symptoms typically begin within 6 to 12 hours of the last dose and peak within 36 to 72 hours.

Long-acting opioids (methadone, extended-release morphine, buprenorphine) have longer half-lives. Withdrawal onset may be delayed 24 to 48 hours or more, with peak symptoms occurring between days 3 and 5. Methadone (Dolophine/Methadose) withdrawal, in particular, can last significantly longer than withdrawal from short-acting substances.

Fentanyl presents a unique challenge. Despite being short-acting in its pharmaceutical form, illicitly manufactured fentanyl and its analogs can accumulate in fatty tissue, sometimes producing a withdrawal timeline that is both rapid in onset and extended in duration.

Early Withdrawal Symptoms (6-24 Hours)

Onset Timing by Substance

The clock starts ticking from the last use of the opioid, but onset varies:

• Heroin: 6 to 12 hours after last dose
• Fentanyl (illicit): As early as 2 to 4 hours in some cases, though timing varies widely
• Oxycodone/hydrocodone: 8 to 16 hours after last dose
• Methadone (Dolophine/Methadose): 24 to 48 hours after last dose
• Buprenorphine (Suboxone/Sublocade): 24 to 72 hours after last dose

These timelines are approximations. Individual factors including metabolism, body composition, liver function, duration of use, and the amount typically consumed all influence when symptoms first appear.

Common Early Signs

Early withdrawal symptoms are often compared to the onset of a bad flu. They include:

• Anxiety and restlessness — often the first noticeable symptom, sometimes accompanied by irritability or a sense of impending dread
• Muscle aches — diffuse pain in the legs, back, and joints that intensifies over the first 24 hours
• Increased tearing (lacrimation) — eyes may water excessively
• Runny nose (rhinorrhea) — nasal drainage without other signs of a cold or allergy
• Excessive sweating — diaphoresis can begin early and persist through acute withdrawal
• Yawning — frequent, deep yawning that is not related to tiredness
• Insomnia — difficulty falling asleep despite physical fatigue

At this stage, symptoms are manageable but tend to escalate. The Clinical Opiate Withdrawal Scale (COWS), used by clinicians to assess severity, measures many of these early indicators to determine when medication-assisted treatment can be safely initiated.

Acute Withdrawal Phase (Days 1-7)

Peak Symptom Period

The acute phase represents the most physically demanding period of opioid withdrawal. For short-acting opioids, symptoms typically peak between 36 and 72 hours after the last dose. During this window, individuals experience the full spectrum of withdrawal effects.

Symptoms during the peak period include:

• Nausea and vomiting — can be severe enough to prevent oral fluid intake
• Diarrhea — often watery and frequent, contributing significantly to dehydration risk
• Abdominal cramping — GI distress is one of the most reported sources of discomfort
• Elevated heart rate (tachycardia) — heart rate may increase by 20 to 40 beats per minute above baseline
• Elevated blood pressure — sympathetic rebound drives hypertension
• Goosebumps (piloerection) — the origin of the colloquial term “cold turkey”
• Dilated pupils (mydriasis) — a key clinical indicator used in COWS scoring
• Intense drug cravings — the combination of physical discomfort and neurochemical imbalance makes this the highest-risk period for return to use

GI Symptoms and Dehydration Risks

Gastrointestinal symptoms deserve particular attention because they represent the most common source of medical complications during opioid withdrawal. Persistent vomiting and diarrhea can lead to:

• Dehydration and electrolyte imbalances — particularly dangerous for individuals with heart conditions, kidney disease, or diabetes
• Aspiration risk — vomiting while sedated or in a weakened state can cause aspiration pneumonia
• Nutritional depletion — inability to eat during peak withdrawal compounds the physiological stress

In clinical settings, IV fluids and electrolyte monitoring are standard practice during this phase. According to SAMHSA’s Treatment Improvement Protocol (TIP) 45, medical supervision during acute opioid withdrawal reduces both symptom severity and the risk of complications.

Post-Acute Withdrawal Syndrome (PAWS)

Duration and Variability

After the acute phase resolves — typically within 7 to 10 days for short-acting opioids and up to 3 weeks for methadone (Dolophine/Methadose) — many individuals enter a protracted withdrawal phase. Post-acute withdrawal syndrome (PAWS) involves lingering symptoms that can persist for weeks, months, or in some cases longer.

PAWS symptoms are primarily psychological and neurological:

• Depression and anhedonia — the brain’s reward system takes time to recalibrate, leaving individuals unable to experience normal pleasure
• Anxiety — generalized anxiety and panic symptoms can persist well beyond the acute phase
• Sleep disturbances — insomnia, fragmented sleep, and vivid or disturbing dreams are among the most persistent complaints
• Cognitive difficulties — problems with concentration, memory, and decision-making
• Drug cravings — can be triggered by environmental cues, stress, or emotional distress
• Fatigue — persistent low energy despite adequate rest
• Irritability and mood swings — emotional regulation difficulties that improve gradually

Managing Long-Term Symptoms

PAWS is a leading contributor to relapse because individuals who have completed acute withdrawal may not expect symptoms to continue. Understanding that these lingering effects are a normal part of neurological recovery — not a sign of failure — is clinically important.

Evidence-based approaches to managing PAWS include:

• Medication-assisted treatment (MAT): Buprenorphine (Suboxone/Sublocade) and naltrexone (Vivitrol) can reduce cravings and stabilize mood during the post-acute period. NIDA research supports long-term MAT as the standard of care for opioid use disorder.
• Behavioral therapies: Cognitive behavioral therapy (CBT) and contingency management help individuals develop coping strategies for persistent symptoms.
• Exercise and sleep hygiene: Regular physical activity and structured sleep routines support neurological recovery.
• Peer support: Recovery community organizations and mutual aid groups provide social reinforcement during a vulnerable period.

When to Seek Medical Help for Opioid Withdrawal

Dangerous Complications

While opioid withdrawal itself is rarely fatal in otherwise healthy individuals, several scenarios warrant immediate medical attention:

• Severe dehydration from uncontrolled vomiting and diarrhea, particularly in individuals with kidney disease, heart failure, or diabetes
• Withdrawal in the context of polysubstance use — concurrent benzodiazepine or alcohol withdrawal can produce seizures and is medically dangerous
• Pregnancy — opioid withdrawal during pregnancy can cause fetal distress, preterm labor, or miscarriage, which is why medication-assisted treatment rather than detox is the standard of care for pregnant individuals
• Pre-existing cardiovascular conditions — the sympathetic surge during withdrawal can stress the heart
• Severe psychiatric symptoms — suicidal ideation during withdrawal requires crisis intervention

Medical Detox Options in New Jersey

New Jersey has expanded access to medically supervised detox through several initiatives. The NJ Division of Mental Health and Addiction Services (DMHAS) maintains a network of licensed treatment providers across the state. Key resources include:

• NJ Substance Abuse Treatment Hotline (1-844-276-2777): Provides referrals to detox and treatment programs throughout the state
• NJ CARES: The state’s coordinated addiction response system connects individuals to treatment within 24 hours
• Naloxone (Narcan) access: New Jersey has a standing order allowing pharmacies to dispense naloxone (Narcan) without a prescription, and the state distributes free naloxone kits through community organizations

Medical detox programs in New Jersey typically use buprenorphine (Suboxone/Sublocade), clonidine, or a combination of symptom-targeted medications to manage withdrawal. According to ASAM guidelines, the goal of medically managed withdrawal is not simply to get through detox, but to transition individuals into ongoing treatment for opioid use disorder.

Detox without follow-up treatment has consistently poor outcomes. NIDA’s research indicates that detox alone, without subsequent medication-assisted treatment or behavioral therapy, is associated with high rates of return to use. The most effective approach combines medical withdrawal management with a planned transition to ongoing treatment.

---

This article is part of our complete guide to opioid addiction in New Jersey. For a deeper look at specific physical symptoms, see our page on physical symptoms of opioid withdrawal. For information on medications used during withdrawal, visit our guide to opioid withdrawal medications and treatment.

For information on medical detox programs, see our resource on medical detox and opioid-specific detox.